Sign In
Buy MBOT
$1.72
-0.0200 (-1.15%)
At Close: Jul 31, 2026
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
08:30am, Monday, 17'th Jun 2024
The Site Initiation Visit for the BWH clinical staff is complete and a shipment of LIBERTY investigational units was delivered The Site Initiation Visit for the BWH clinical staff is complete and a sh
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
04:20pm, Tuesday, 04'th Jun 2024
HINGHAM, Mass., June 04, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has closed its previously announced registered direct offering priced at-the-market under
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
12:11pm, Monday, 03'rd Jun 2024
HINGHAM, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced that it has entered into definitive agreements for the purchase and sale of 1,566,669 shares of t
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
08:20am, Monday, 03'rd Jun 2024
The trial will be conducted in the U.S. and its results will complement the preclinical data on the LIBERTY® Endovascular Robotic Surgical System, which together are expected to support a future 510(
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
08:30am, Monday, 29'th Apr 2024
The next step of the collaboration will explore potential future applications of the LIBERTY system, including its potential capabilities for remote endovascular procedures The next step of the collab
Microbot Medical Shares Status Following Recent Geopolitical Events
08:30am, Monday, 15'th Apr 2024
All Regulatory, Clinical, Operational and Pre-Commercial Activities Continue to Stay on Track Despite the On-going Situation in Israel
Microbot Medical (MBOT) Files IDE to Start Human Clinical Study
11:11am, Wednesday, 07'th Feb 2024
Microbot Medical (MBOT) files an IDE with the FDA, approval of which will enable the company to proceed with its human clinical study in the United States.
Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the US
07:30am, Monday, 05'th Feb 2024
The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this application The Investigational Device Exemption (IDE) application follows t
Microbot Medical Announces Settlement and Release Agreement, Effectively Resolving all Associated Legal Matters
07:20am, Tuesday, 30'th Jan 2024
All of the cash payable to the plaintiffs in the settlement will be covered by Microbot's insurance carrier and will not impact company's cash position All of the cash payable to the plaintiffs in the
Following the recent positive results of its pivotal GLP pre-clinical study, the Company added a CRA to facilitate the company's first in human clinical study Following the recent positive results of
Microbot Medical (MBOT) Announces Positive GLP Study Results
11:16am, Wednesday, 03'rd Jan 2024
Microbot Medical's (MBOT) latest favorable study results are likely to support its IDE submission to the FDA to commence its human clinical study.
BRAINTREE, Mass., Dec. 29, 2023 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic Surgical System, today announced the entry into a d
Microbot Medical is Set to Progress its Liberty Robotic System into Pivotal Clinical Trial; Shares soar 60%
02:51pm, Thursday, 28'th Dec 2023
New York, December 28, 2023 – Microbot Medical Inc. (Nasdaq: MBOT) has completed its GLP pivotal pre-clinical study for the LIBERTY® Endovascular Robotic Surgical System. The study, adhering to
Microbot Medical Announced Positive Results of Its GLP Pivotal Pre-Clinical Study Where All Study Objectives Were Met
07:30am, Thursday, 28'th Dec 2023
The results of the study will support the Company's IDE submission to the FDA to commence its human clinical study The results of the study will support the Company's IDE submission to the FDA to comm
Microbot Medical and Corewell Health Forge Collaboration to Establish the LIBERTY® Endovascular Robotic Surgical System for Telerobotic
08:15am, Thursday, 14'th Dec 2023
The first phase in the collaboration will evaluate the current state of the LIBERTY® Robotic Surgical System in connection with remote enabled Endovascular treatments The first phase in the collabora
